BioCryst To Present New Data For BCX4208 Monotherapy At The 74th Annual American College Of Rheumatology (ACR) Scientific Meeting

Links shared publicly online about this topic.

  • 737
    total visits

BioCryst To Present New Data For BCX4208 Monotherapy At The 74th Annual American College Of Rheumatology (ACR) Scientific Meeting

medicalnewstoday.com —

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) announced the presentation of new data related to the efficacy and safety of BCX4208 for the treatment of gout at the 74th ACR Scientific Meeting bein

View full resource at medicalnewstoday.com

Tags: Crystal Disorders, Gout, Pharma, Rheumatology, Education, Safety

  • Share

Most Recently Shared on November 10, 2010 at 6:05 pm By:

mnt_pharma MNT Pharma News

BioCryst To Present New Data For BCX4208 Monotherapy At The 74th Annual American College Of Rheumatology (ACR) Scienti... http://mnt.to/3Mm4

1 year ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Arthritis News MNT Arthritis News

MNT Gout MNT Gout

MNT Med Conferences MNT Med Conferences

Advertisement